JOSEPH HORETSKI: Open Payments
NPI 1306530548 · AUBURN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,974 in 76 payments from 13 companies in 2025. Trend: 2023 $1,638 · 2024 $2,500 · 2025 $1,974
Food & beverage: $1,863Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $466 |
| Axsome Therapeutics, Inc. | 10 | $352 |
| Otsuka America Pharmaceutical, Inc. | 8 | $264 |
| Janssen Pharmaceuticals, Inc | 7 | $190 |
| Neurocrine BioSciences, Inc. | 13 | $180 |
| E.R. Squibb & Sons, L.L.C. | 4 | $163 |
| Lundbeck LLC | 10 | $152 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| ABBVIE INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: Auvelity, REXULTI, INGREZZA, SPRAVATO, COBENFY, AUSTEDO XR, UZEDY, ABILIFY MAINTENA.
Industry payments across MI — which companies pay providers there.
